Literature DB >> 32468716

The CRISPR babies controversy: Responsibility and regulation in the spotlight.

Morgan Meyer1.   

Abstract

The genome editing of human embryos by He Jianjui and the announcement to do so by Denis Rebrikov should spur the research community into discussing robust and transparent governance for human germline modificition.
© 2020 The Author.

Entities:  

Mesh：

Year:  2020        PMID： 32468716      PMCID： PMC7332977          DOI： 10.15252/embr.202050307

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


  5 in total

1.  Act now on CRISPR babies.

Authors: 
Journal:  Nature       Date:  2019-06       Impact factor: 49.962

2.  Russian biologist plans more CRISPR-edited babies.

Authors:  David Cyranoski
Journal:  Nature       Date:  2019-06       Impact factor: 49.962

3.  The CRISPR babies controversy: Responsibility and regulation in the spotlight.

Authors:  Morgan Meyer
Journal:  EMBO Rep       Date:  2020-05-28       Impact factor: 8.807

4.  A CRISPR Moratorium Isn't Enough: We Need a Boycott.

Authors:  Soren H Hough; Ayokunmi Ajetunmobi
Journal:  CRISPR J       Date:  2019-12

5.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870
  5 in total
  2 in total

1.  The CRISPR babies controversy: Responsibility and regulation in the spotlight.

Authors:  Morgan Meyer
Journal:  EMBO Rep       Date:  2020-05-28       Impact factor: 8.807

Review 2.  CRISPR-Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing.

Authors:  Irina Gostimskaya
Journal:  Biochemistry (Mosc)       Date:  2022-08       Impact factor: 2.824
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.